Performance of the manual and Sofia rapid antigen test in medical staff exposed to Omicron variants
DOI:
https://doi.org/10.3396/ijic.v20.23502Keywords:
rapid antigen test, Sofia, real-time PCR, SARS CoV-2, COVID-19, medical staff, QatarAbstract
Background: Variable COVID-19 rapid antigen test sensitivity had been reported and the effect of viral variants drew attention to the impact in the early detection of cases.
Objective: The study aims to compare the performance of antigen tests (manual rapid antigen tests [RAT], and Sofia test) in medical staff exposed during the circulation periods of different Omicron variants.
Methods: The descriptive study of samples collected for the diagnosis of SARS-CoV-2 infection included medical staff at The Cuban Hospital (TCH) Hospital repeated from December 2021 to December 2022, including cases confirmed by SARS CoV-2 polymerase chain reaction (PCR), and a RAT. December 2021–March 2022 and June-December 2022 were considered the periods of Omicron BA.1.1. variants and Omicron BA.4/5 respectively. Comparison of Ct figures between categories was carried out using the Wilcoxon–Mann–Whitney test, and sensitivity (95% confidence intervals [CI]) values were calculated. Results: 287 healthcare workers were diagnosed with COVID-19 during the study period, 56.1% during the B.1.1. variant period, and 43.9% when B.4/5 variants were predominantly in circulation. Sensitivity of the manual RAT test (82.5%; 95% CI 73.4–89.4) was higher during the B.1.1. variant circulation in comparison with the B.4/5 period (68.9%;53.4–81.8). These two methods during this B.4/5 period had quite similar sensitivity figures when compared to each other; manual 68.9% (95% CI 53.4–81.8) and Sofia 72.7% (95% CI 60.4–83.0).
Conclusion: The variation in sensitivity of the RAT for SARS CoV-2 variants and the similar performance of manual and SOFIA methods of RAT could be considered in the diagnostic approach of COVID-19 and the appropriate isolation of potentially infectious cases.
Downloads
References
1. Fernandes Q, Inchakalody VP, Merhi M, Mestiri S, Taib N, Moustafa Abo El-Ella D, et al. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines. Ann Med 2022; 54(1): 524–40. doi: 10.1080/07853890.2022.2031274
2. Rai P, Kumar BK, Deekshit VK, Karunasagar I, Karunasagar I. Detection technologies and recent developments in the diagnosis of COVID-19 infection. Appl Microbiol Biotechnol 2021; 105(2): 441–55. doi: 10.1007/s00253-020-11061-5
3. Smith RD, Johnson JK, Clay C, Girio-Herrera L, Stevens D, Abraham M, Zimand P, et al. Clinical evaluation of Sofia Rapid Antigen Assay for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among emergency department to hospital admissions. Infect Control Hosp Epidemiol 2022; 43(8): 968–73. doi: 10.1017/ice.2021.281
4. Dinnes J, Deeks JJ, Berhane S, Taylor M, Adriano A, Davenport C, et al. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 2021; 3(3): CD013705. doi: 10.1002/14651858.CD013705.pub2. Update in: Cochrane Database Syst Rev. 2022 Jul 22;7:CD013705.
5. Jegerlehner S, Suter-Riniker F, Jent P, Bittel P, Nagler M. Diagnostic accuracy of a SARS-CoV-2 rapid antigen test in real-life clinical settings. Int J Infect Dis 2021; 109: 118–22. doi: 10.1016/j.ijid.2021.07.010
6. Bornemann L, Kaup O, Kleideiter J, Panning M, Ruprecht B, Wehmeier M. Real-life evaluation of the Sofia SARS-CoV-2 antigen assay in a large tertiary care hospital. J Clin Virol 2021; 140: 104854. doi: 10.1016/j.jcv.2021.104854
7. Brihn A, Chang J, OYong K, Balter S, Terashita D, Rubin Z, et al. Diagnostic performance of an antigen test with RT-PCR for the detection of SARS-CoV-2 in a hospital setting – Los Angeles County, California, June-August 2020. MMWR Morb Mortal Wkly Rep 2021; 70(19): 702–6. doi: 10.15585/mmwr.mm7019a3
8. World Health Organization. Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays. Interim guidance 6 October 2021. Available from: https://iris.who.int/bitstream/handle/10665/345948/WHO-2019-nCoV-Antigen-Detection-2021.1-eng.pdf [cited 15 January 2024].
9. Gómez-Ochoa SA, Franco OH, Rojas LZ, Raguindin PF, Roa-Díaz ZM, Wyssmann BM, et al. COVID-19 in health-care workers: a living systematic review and meta-analysis of prevalence, risk factors, clinical characteristics, and outcomes. Am J Epidemiol. 2021; 190(1): 161–75. doi: 10.1093/aje/kwaa191
10. Alajmi J, Jeremijenko AM, Abraham JC, Alishaq M, Concepcion EG, Butt AA, et al. COVID-19 infection among healthcare workers in a national healthcare system: the Qatar experience. Int J Infect Dis 2020; 100: 386–9. doi: 10.1016/j.ijid.2020.09.027
11. Panbio. Panbio COVID-19 Ag (nasal) instructions for use. 41FK11/41FK21-01-EN-A1.2021.01. Jena: Abbott Rapid Diagnostics Jena GmbH; 2021.
12. Sofia®. SARS Antigen FIA [package insert, EUA]. San Diego, CA: Quidel Corporation; 2020.
13. Fourati S, Langendorf C, Audureau E, Challine D, Michel J, Soulier A, et al. Performance of six rapid diagnostic tests for SARS-CoV-2 antigen detection and implications for practical use. J Clin Virol 2021; 142: 104930. doi: 10.1016/j.jcv.2021.104930
14. Landaas ET, Storm ML, Tollånes MC, Barlinn R, Kran AB, Bragstad K, et al. Diagnostic performance of a SARS-CoV-2 rapid antigen test in a large, Norwegian cohort. J Clin Virol 2021; 137: 104789. doi: 10.1016/j.jcv.2021.104789
15. Möckel M, Corman VM, Stegemann MS, Hofmann J, Stein A, Jones TC, et al. SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department. Biomarkers 2021; 26(3): 213–20. doi: 10.1080/1354750X.2021.1876769
16. Krüttgen A, Cornelissen CG, Dreher M, Hornef MW, Imöhl M, Kleines M. Comparison of the SARS-CoV-2 Rapid antigen test to the real star Sars-CoV-2 RT PCR kit. J Virol Methods. 2021; 288: 114024. doi: 10.1016/j.jviromet.2020.114024
17. Wölfl-Duchek M, Bergmann F, Jorda A, Weber M, Müller M, Seitz T, et al. Sensitivity and specificity of SARS-CoV-2 rapid antigen detection tests using oral, anterior nasal, and nasopharyngeal swabs: a Diagnostic Accuracy Study. Microbiol Spectr 2022; 10(1): e0202921. doi: 10.1128/spectrum.02029-21
18. Hartard C, Berger S, Josse T, Schvoerer E, Jeulin H. Performance evaluation of an automated SARS-CoV-2 Ag test for the diagnosis of COVID-19 infection on nasopharyngeal swabs. Clin Chem Lab Med 2021; 59(12): 2003–9. doi: 10.1515/cclm-2021-0569
19. Albert E, Torres I, Bueno F, Huntley D, Molla E, Fernández-Fuentes MÁ, et al. Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres. Clin Microbiol Infect 2021; 27(3): 472.e7–472.e10. doi: 10.1016/j.cmi.2020.11.004
20. Galliez RM, Bomfim L, Mariani D, Leitão IC, Castiñeiras ACP, Gonçalves CCA, Ortiz da Silva B, et al. Evaluation of the Panbio COVID-19 antigen rapid diagnostic test in subjects infected with omicron using different specimens. Microbiol Spectr 2022; 10(3): e0125022. doi: 10.1128/spectrum.01250-22
21. Cocherie T, Bastide M, Sakhi S, Zafilaza K, Flandre P, Leducq V, et al. Decreased sensitivity of rapid antigen test is associated with a lower viral load of omicron than delta SARS-CoV-2 variant. Microbiol Spectr 2022; 10(5): e0192222. doi: 10.1128/spectrum.01922-22
22. Soni A, Herbert C, Filippaios A, Broach J, Colubri A, Fahey N, et al. Comparison of Rapid antigen tests’ performance between delta and omicron variants of SARS-CoV-2: a secondary analysis from a serial home self-testing study. Ann Intern Med 2022; 175(12): 1685–92. doi: 10.7326/M22-0760
23. Kyritsi MA, Speletas M, Mouchtouri V, Vachtsioli E, Babalis D, Kouliou O, et al. Performance evaluation of a rapid antigen test (RAT) during omicron pandemic wave in Greece, conducted by different personnel, and comparison with performance in previous wave (Alpha Variant) period. Diagnostics (Basel) 2022; 12(5): 1048. doi: 10.3390/diagnostics12051048
24. Leuzinger K, Roloff T, Egli A, Hirsch HH. Impact of SARS-CoV-2 omicron on rapid antigen testing developed for early-pandemic SARS-CoV-2 variants. Microbiol Spectr 2022; 10(4): e0200622. doi: 10.1128/spectrum.02006-22
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Humberto Guanche Garcell, Eduardo Vargas Girón, Sandra Ibis Gonzalez Perez, Angel M Felipe Garmendia, Francisco Gutierrez Garcia
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright of their work, with first publication rights granted to IJIC. Read the full Copyright- and Licensing Statement.
